Parasite Glycobiology: A Bittersweet Symphony

Human infections caused by parasitic protozoans and helminths are among the world's leading causes of death. More than a million people die each year from diseases like malaria and neglected tropical diseases like leishmaniasis, trypanosomiasis, and schistosomiasis. Patients also endure disabil...

Descripción completa

Detalles Bibliográficos
Autores: Rodrigues, Joao A., Acosta-Serrano, Alvaro, Aebi, Markus, Ferguson, Michael A. J., Routier, Françoise H., Schiller, Irene, Soares, Simão, Spencer, Daniel, Titz, Alexander, Wilson, Iain B. H., Izquierdo Lázaro, Luis
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/69169
Acceso en línea:https://hdl.handle.net/2445/69169
Access Level:acceso abierto
Palabra clave:Malalties parasitàries
Relacions hoste-paràsit
Enzimologia
Glicoproteïnes
Glicolípids
Parasitic diseases
Host-parasite relationships
Enzymology
Glycoproteins
Glycolipids
Descripción
Sumario:Human infections caused by parasitic protozoans and helminths are among the world's leading causes of death. More than a million people die each year from diseases like malaria and neglected tropical diseases like leishmaniasis, trypanosomiasis, and schistosomiasis. Patients also endure disabilities that cause lifelong suffering and that affect productivity and development. More insidiously, parasites generate important economic losses, since they often also infect commercially valuable animals. Worldwide, exposure to parasites is increasing due to growing international travel and migrations, as well as climate changes, which affect the geographic distribution of the parasite vectors. The parasitic threat is also aggravated by the rise of the immunocompromised population, which is particularly sensitive to parasite infections (e.g., individuals with AIDS and other immunodeficiencies).